Joseph Truitt
2018
In 2018, Joseph Truitt earned a total compensation of $3.3M as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 209% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $255,640 |
---|---|
Option Awards | $2,502,220 |
Salary | $509,400 |
Other | $8,731 |
Total | $3,275,991 |
Truitt received $2.5M in option awards, accounting for 76% of the total pay in 2018.
Truitt also received $255.6K in non-equity incentive plan, $509.4K in salary and $8.7K in other compensation.
Rankings
In 2018, Joseph Truitt's compensation ranked 3,511th out of 14,244 executives tracked by ExecPay. In other words, Truitt earned more than 75.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,511 | 75th |
Manufacturing | 1,297 | 78th |
Chemicals And Allied Products | 455 | 79th |
Drugs | 375 | 79th |
Pharmaceutical Preparations | 288 | 79th |
Truitt's colleagues
We found five more compensation records of executives who worked with Joseph Truitt at Achillion Pharmaceuticals in 2018.
2018
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
2018
Steven Zelenkofske
Achillion Pharmaceuticals
Chief Medical Officer
2018
Paul Firuta
Achillion Pharmaceuticals
Chief Operating Officer
2018
Mary Fenton
Achillion Pharmaceuticals
Chief Financial Officer
2018
Anthony Gibney
Achillion Pharmaceuticals